IHH Healthcare Berhad Valuation

Is IHH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of IHH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: IHH (MYR6.34) is trading below our estimate of fair value (MYR9.45)

Significantly Below Fair Value: IHH is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for IHH?

Other financial metrics that can be useful for relative valuation.

IHH key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue3.1x
Enterprise Value/EBITDA12.2x
PEG Ratio-92.6x

Price to Earnings Ratio vs Peers

How does IHH's PE Ratio compare to its peers?

The above table shows the PE ratio for IHH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average22.1x
KPJ KPJ Healthcare Berhad
26.4x7.4%RM 8.1b
FOCUSP Focus Point Holdings Berhad
12.4x11.0%RM 392.7m
CENGILD Cengild Medical Berhad
21.9xn/aRM 258.2m
BDMS Bangkok Dusit Medical Services
27.8x8.1%฿417.2b
IHH IHH Healthcare Berhad
24x-0.3%RM 55.9b

Price-To-Earnings vs Peers: IHH is expensive based on its Price-To-Earnings Ratio (24x) compared to the peer average (22.1x).


Price to Earnings Ratio vs Industry

How does IHH's PE Ratio compare vs other companies in the Asian Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a1.3%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a1.3%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: IHH is expensive based on its Price-To-Earnings Ratio (24x) compared to the Asian Healthcare industry average (23.3x).


Price to Earnings Ratio vs Fair Ratio

What is IHH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

IHH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24x
Fair PE Ratio28.5x

Price-To-Earnings vs Fair Ratio: IHH is good value based on its Price-To-Earnings Ratio (24x) compared to the estimated Fair Price-To-Earnings Ratio (28.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst IHH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 6.34
RM 7.26
+14.5%
6.2%RM 8.00RM 6.40n/a21
Jul ’25RM 6.30
RM 7.26
+15.2%
6.2%RM 8.00RM 6.40n/a21
Jun ’25RM 6.19
RM 7.22
+16.7%
6.0%RM 7.90RM 6.40n/a20
May ’25RM 6.33
RM 7.13
+12.6%
6.4%RM 7.88RM 6.40n/a20
Apr ’25RM 6.08
RM 7.13
+17.3%
6.4%RM 7.88RM 6.40n/a20
Mar ’25RM 6.14
RM 7.08
+15.3%
6.4%RM 7.86RM 6.17n/a19
Feb ’25RM 6.10
RM 7.03
+15.2%
6.3%RM 7.70RM 6.30n/a18
Jan ’25RM 6.03
RM 7.00
+16.1%
6.3%RM 7.70RM 6.30n/a17
Dec ’24RM 5.84
RM 7.00
+19.9%
6.1%RM 7.70RM 6.30n/a18
Nov ’24RM 5.99
RM 7.00
+16.9%
6.2%RM 7.70RM 6.22n/a18
Oct ’24RM 5.85
RM 7.02
+20.0%
6.0%RM 7.70RM 6.22n/a19
Sep ’24RM 5.88
RM 7.04
+19.7%
5.9%RM 7.70RM 6.22n/a20
Aug ’24RM 5.94
RM 7.08
+19.2%
6.0%RM 7.70RM 6.28n/a21
Jul ’24RM 5.89
RM 7.06
+19.8%
6.1%RM 7.70RM 6.28RM 6.3022
Jun ’24RM 5.74
RM 7.06
+23.1%
5.5%RM 7.63RM 6.30RM 6.1922
May ’24RM 5.73
RM 7.09
+23.8%
6.0%RM 7.80RM 6.30RM 6.3321
Apr ’24RM 5.75
RM 7.11
+23.6%
5.9%RM 7.80RM 6.30RM 6.0821
Mar ’24RM 5.71
RM 7.15
+25.2%
6.5%RM 7.90RM 6.30RM 6.1420
Feb ’24RM 5.92
RM 7.21
+21.8%
6.0%RM 7.90RM 6.38RM 6.1020
Jan ’24RM 6.22
RM 7.23
+16.3%
6.0%RM 7.90RM 6.38RM 6.0321
Dec ’23RM 5.79
RM 7.25
+25.2%
5.8%RM 7.90RM 6.38RM 5.8421
Nov ’23RM 5.97
RM 7.48
+25.3%
6.0%RM 8.30RM 6.70RM 5.9921
Oct ’23RM 5.90
RM 7.52
+27.4%
5.7%RM 8.30RM 6.70RM 5.8520
Sep ’23RM 6.18
RM 7.56
+22.3%
5.6%RM 8.30RM 6.70RM 5.8820
Aug ’23RM 6.50
RM 7.54
+16.0%
7.7%RM 8.40RM 5.60RM 5.9420
Jul ’23RM 6.48
RM 7.54
+16.4%
7.7%RM 8.40RM 5.60RM 5.8920

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.